Biosafety levels (BSL-1 through BSL-4) describe escalating combinations of laboratory practices, safety equipment, and facility safeguards—not fixed danger ratings for individual pathogens. The level and controls needed depend on the specific work, including the agent, procedures, exposure routes, and likelihood of aerosols or splashes. In the United States, the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) is advisory guidance; applicable laws, institutional policies, and agent-specific requirements may also apply.
What a biosafety level describes
A biosafety level is a framework for organizing containment. CDC and NIH describe each level through four connected elements: standard microbiological practices, special practices, safety equipment, and laboratory facilities. As the levels rise, the measures generally provide greater protection for personnel, the environment, and the community. The BMBL sixth edition explains these US criteria and remains advisory guidance, according to the CDC’s page, updated March 18, 2026: CDC: Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition.
The World Health Organization’s 2020 fourth edition of the Laboratory Biosafety Manual likewise emphasizes a risk- and evidence-based approach: assess the actual activity first, then select controls appropriate to its risks. Its guidance addresses risk assessment, laboratory design and maintenance, biological safety cabinets and other primary containment, personal protective equipment, decontamination and waste management, biosafety program management, and outbreak preparedness: WHO: Laboratory biosafety manual, fourth edition.
How BSL-1, BSL-2, BSL-3, and BSL-4 differ
The levels are useful shorthand for increasing containment, but they are not universal pathogen labels. The appropriate measures depend on both the biological agent and the work being performed.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
| Level | Plain-language purpose | Typical emphasis |
|---|---|---|
| BSL-1 | Basic containment for characterized agents not known to consistently cause disease in healthy adults. | Standard microbiological practices; work is typically performed on an open bench. Special containment equipment or facility design is generally not required, subject to risk assessment. |
| BSL-2 | Work with agents associated with human disease and moderate hazards. | Builds on BSL-1 with specific training and supervision, restricted access while work is in progress, and a biological safety cabinet or other physical containment for procedures that may generate infectious aerosols or splashes. |
| BSL-3 | Work involving potentially serious or lethal agents, especially when inhalation exposure is a concern. | Adds heightened practices and engineering or facility controls. The required safeguards depend on protocol-driven risk assessment, not simply the agent’s name. |
| BSL-4 | The highest level of containment for the highest-risk work. | Uses the most stringent combination of practices, equipment, and facility safeguards. The level applies to assessed activities and their risks, not merely to a room or a list of pathogens. |
This overview reflects the CDC/NIH BMBL; it is not a substitute for its detailed criteria or the rules applicable to a particular institution or jurisdiction.
Why a pathogen does not always have one fixed BSL
A pathogen’s name alone does not determine the containment level for every task involving it. Risk assessment considers the agent, how it can expose people, the procedure, and the safeguards available. For example, a procedure likely to produce infectious aerosols or splashes raises different containment questions from work that does not create those exposure opportunities. Training, access controls, primary barriers, personal protective equipment, and facility engineering are also part of the decision.
Rank #2
The BMBL’s core principle is protocol-driven risk assessment. As Brandon Hatcher, PhD, RBP, CBSP, Director of CDC’s Office of Laboratory Safety, states in its foreword: “The core principle of this document is protocol-driven risk assessment; it is not possible for a single document to identify all of the possible combinations of risks and mitigations feasible in biomedical and clinical laboratories.” The CDC’s BMBL page provides the sixth edition and explains its advisory status: CDC: BMBL sixth edition.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Biosafety and biosecurity address different risks
Biosafety concerns preventing accidental exposure or release through safe work practices and containment. Biosecurity concerns preventing deliberate or unauthorized access, theft, misuse, or loss of high-consequence biological materials and related information. The WHO’s 2024 biosecurity guidance addresses biological risk management across collection, transport, storage, and research, and complements its biosafety manual: WHO: Laboratory biosecurity guidance.
Quick Recap
Rank #4
What to check before applying a BSL label
- Jurisdiction and institutional rules: The BMBL is US advisory guidance, not by itself a regulation. Local laws, institutional biosafety committee requirements, funder rules, and agent-specific requirements may also govern the work.
- Activity-specific assessment: Consider the agent and exposure routes, procedure-related aerosol or splash risks, barriers and PPE, facility safeguards, personnel training, and access controls together.
- Current guidance: Use the BMBL sixth edition for detailed US criteria and the WHO Laboratory Biosafety Manual, fourth edition, for its international, risk-based framework. Neither replaces a work-specific assessment.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
